Obtained Masters of Technology in Bioinformatics from University of Hyderabad and Bachelors of Technology in Computer Science and Information Technology from Sree Visvesvaraya Institute of Technology & Science, Jawaharlal Nehru Technological University, Hyderabad.

My research is focused on Bioinformatics & Software to evaluate life science biological problems and provide solutions by Computational & Structural Bioinformatics approach. Biological data interpretations, Structural Genomics & annotations, and Transcriptome analysis, Translational and applied Bioinformatics, Genomics sequence analysis, Next-generation sequencing data analysis (DNA-seq, RNA-seq). Molecular homology modeling, drug discovery, ADME, molecular docking, molecular dynamics and simulations, Cheminformatics, Micro-array analysis, Pipeline deployment, ICD-O-3/ ICD-10 codes.

1. Thrigulla Saketh Ram, Manne Munikumar, Vankudavath Naik Raju, Parasannanavar Devaraj, Naveen Kumar Boiroju, Rajkumar Hemalatha, PVV Prasad, Manohar Gundeti, Brijesh S Sisodia, Sharad Pawar, GP Prasad, Mukesh Chincholikar, Sumeet Goel, Anupam Mangal, Sudesh Gaidhani, N Srikanth, KS Dhiman. In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease. Journal of Ayurveda and integrative medicine. 2022 Jan 1. 13 1 100413

2. Vankudavath Raju Naik, Manne Munikumar, Ungarala Ramakrishna, Medithi Srujana, Giridhar Goudar, Pittla Naresh, Boiroju Naveen Kumar, Rajkumar Hemalatha. Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease – in silico approach. Journal of Biomolecular Structure and Dynamics. 2021 Sep 2. 39 13 4701-4714

3. Donugama Vasundhara, Vankudavath Naik Raju, Rajkumar Hemalatha, Ravinder Nagpal, Manoj Kumar. Vaginal & gut microbiota diversity in pregnant women with bacterial vaginosis & effect of oral probiotics: an exploratory study. Indian Journal of Medical Research. 2021 Apr 1. 153 4 492-502

4. Vasanthi Siruguri, Dinesh Kumar Bharatraj, Raju Naik Vankudavath, Vishnu Vardhana Rao Mendu, Vibha Gupta, Richard E Goodman. Evaluation of Bar, Barnase, and Barstar recombinant proteins expressed in genetically engineered Brassica juncea (Indian mustard) for potential risks of food allergy using bioinformatics and literature searches. Food and Chemical Toxicology. 2015 Sep 1. 83 93-102

5. Kowshik J, Giri H, Kiran Kishore TK, Kesavan R, Vankudavath RN, Reddy GB, Dixit M, Nagini S. Ellagic Acid Inhibits VEGF/VEGFR2, PI3K/Akt and MAPK Signaling Cascades in the Hamster Cheek Pouch Carcinogenesis Model. Anticancer Agents Med Chem. 2014 Jul 23.

6. Rajkumar H, Ramagoni RK, Anchoju VC, Vankudavath RN, Syed AUZ (2015) De Novo Transcriptome Analysis of Allium cepa L. (Onion) Bulb to Identify Allergens and Epitopes. PLoS ONE. 2015 Aug 18. 10(8): e0135387. https://doi.org/10.1371/journal.pone.0135387 (Impact factor:2.806)

7. Ankulu Ma, Aparna.Na, Amol Shirfulea, Raju Naik Vankudavathb, Arjun .L. Khandare a. Putative ligand-target docking studies of human AMPA selective Ionotropic glutamate receptors reveal that beta-ODAP has high binding affinity compared to tyrosine and glutamate. Int Res J Biochem and Bioinfo. 2013 Aug, Vol.3(8).

8. Sharma N, Ethiraj KR, Yadav M, Nayarisseri A, Chaurasiya M, Vankudavath RN, Rao KR. Identification of LOGP values and Electronegativities as structural insights to model inhibitory activity of HIV-1 Capsid Inhibitors - A SVM and MLR aided QSAR studies. Curr Top Med Chem. 2012 Sep 2 (Impact factor: 4.9)

9. Chetan C. Nimgulkar, Raju Naik Vankudavath, Sudip Ghosh, K. Bhaskarachary, B. Dinesh Kumar. In-silico and in-vivo validation of herbal and nutraceutical combination as anti-inflammatory agent. Indian J Pharma. 2011 Dec. Vol 43, G-Achari Prize-9, supplement 1-S199. (Impact factor: 0.691)

10. Vankadavath RN, Hussain AJ, Bodanapu R, Kharshiing E, Basha PO, Gupta S, Sreelakshmi Y, Sharma R (2009) Computer aided data acquisition tool for high-throughput phenotyping of plant populations. Plant Methods 5:18. 2009. doi:10.​1186/​1746-4811-5-18 (PMID: 20003250). 2009 Vankadavath et al; licensee BioMed Central Ltd. (Impact factor: 3.510)